Your browser doesn't support javascript.
loading
Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on front-line imatinib.
Nicolini, Franck Emmanuel; Alcazer, Vincent; Cony-Makhoul, Pascale; Heiblig, Maël; Morisset, Stéphane; Fossard, Gaëlle; Bidet, Audrey; Schmitt, Anna; Sobh, Mohamad; Hayette, Sandrine; Mahon, François-Xavier; Dulucq, Stéphanie; Etienne, Gabriel.
Affiliation
  • Nicolini FE; Hematology Department, Centre Léon Bérard, Lyon, France; INSERM U1052, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Lyon, France; Groupe Fi-LMC, Institut Bergonié, Bodeaux, France. Electronic address: franck-emmanuel.nicolini@lyon.unicancer.fr.
  • Alcazer V; Hematology Department, Centre Léon Bérard, Lyon, France.
  • Cony-Makhoul P; Hematology Department, Centre Hospitalier Annecy-Genevois, Epagny Metz-Tessy, France; Groupe Fi-LMC, Institut Bergonié, Bodeaux, France.
  • Heiblig M; Hematology Department, Centre Léon Bérard, Lyon, France.
  • Morisset S; Hematology Department, Centre Léon Bérard, Lyon, France.
  • Fossard G; INSERM U1052, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Lyon, France.
  • Bidet A; Laboratory for Hematology, Hôpital Haut Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France.
  • Schmitt A; Hematology Department, Institut Bergonié, Bordeaux, France.
  • Sobh M; Hematology Department, Centre Léon Bérard, Lyon, France.
  • Hayette S; Laboratory for Hematology and Molecular Biology, Centre Hospitalier Lyon Sud, Piere-Bénite, France; Groupe Fi-LMC, Institut Bergonié, Bodeaux, France.
  • Mahon FX; Hematology Department, Institut Bergonié, Bordeaux, France; Groupe Fi-LMC, Institut Bergonié, Bodeaux, France.
  • Dulucq S; Laboratory for Hematology, Hôpital Haut Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France; Groupe Fi-LMC, Institut Bergonié, Bodeaux, France.
  • Etienne G; Hematology Department, Institut Bergonié, Bordeaux, France; Groupe Fi-LMC, Institut Bergonié, Bodeaux, France.
Exp Hematol ; 64: 97-105.e4, 2018 08.
Article in En | MEDLINE | ID: mdl-29800673
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Chronic-Phase / Protein Kinase Inhibitors / Imatinib Mesylate / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Exp Hematol Year: 2018 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Chronic-Phase / Protein Kinase Inhibitors / Imatinib Mesylate / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Exp Hematol Year: 2018 Document type: Article Country of publication: Netherlands